Chromatographic retention of drug molecules on immobilised liposomes prepared from egg phospholipids and from chemically pure phospholipids.
about
A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulationsPhysicochemical selectivity of the BBB microenvironment governing passive diffusion--matching with a porcine brain lipid extract artificial membrane permeability model.Biorelevant pK(a) (37 °C) predicted from the 2D structure of the molecule and its pK(a) at 25 °C.Modeling kinetics of subcellular disposition of chemicals.Lipophilicity and its relationship with passive drug permeation.Advances in LC platforms for drug discovery.Correlation between octanol/water and liposome/water distribution coefficients and drug absorption of a set of pharmacologically active compounds.Molecular dynamics simulations of the interactions of medicinal plant extracts and drugs with lipid bilayer membranes.Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.Advances in immobilized artificial membrane (IAM) chromatography for novel drug discovery.Partitioning of organic compounds in phases imitating the headgroup and core regions of phospholipid bilayers.Effects of cholesterol and model transmembrane proteins on drug partitioning into lipid bilayers as analysed by immobilized-liposome chromatography.Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations.Application of genetic algorithm-kernel partial least square as a novel non-linear feature selection method: partitioning of drug molecules.pK(a) modelling and prediction of drug molecules through GA-KPLS and L-M ANN.Research on drug-receptor interactions and prediction of drug activity via oriented immobilized receptor capillary electrophoresis.Determination of partitioning of drug molecules using immobilized liposome chromatography and chemometrics methods.
P2860
Q34031018-06CFD5DF-7701-4AFA-A1DE-04CF17A71A1AQ34556508-3556EDF5-7264-4797-ADBD-A600EB87F80CQ35098717-200F16B1-53B7-4F8D-B01C-819B4FEABF4CQ37194304-CD688178-CF5B-4DDF-848D-9AF2CDCA71FBQ37807276-01D5EE20-CB07-481A-9EE2-4F20E3D42B53Q38028548-7245332D-171E-4E12-9EEA-07CEF188A305Q38086939-5D0639A7-B2D2-43EE-A018-F8E107A60F53Q38099377-D9A11918-EA47-48F0-A72C-B42D9E166327Q38117056-F485FEA8-F1FE-4043-A480-D61470F75B00Q38769803-9175F66A-8C22-4468-87B8-5E1D5D455586Q42706885-069D8705-CA5D-4C26-B9C0-580B071C3E7DQ43815268-D588FA32-8F0C-45E9-B37B-4C46589345E9Q44630513-6F3427E2-4A39-4708-BBCD-E9C008D2DA2AQ45023101-69DBE00C-F919-436B-B906-7E03B33E7EC6Q45911784-4005E1C9-7275-4A59-A9E4-6A38107D3106Q50893787-D77E72C0-CDE1-4C37-BD03-4E374050DDF0Q51585686-D9CA72AA-6303-4D4F-B133-69DCEDCADE0E
P2860
Chromatographic retention of drug molecules on immobilised liposomes prepared from egg phospholipids and from chemically pure phospholipids.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Chromatographic retention of d ...... chemically pure phospholipids.
@ast
Chromatographic retention of d ...... chemically pure phospholipids.
@en
type
label
Chromatographic retention of d ...... chemically pure phospholipids.
@ast
Chromatographic retention of d ...... chemically pure phospholipids.
@en
prefLabel
Chromatographic retention of d ...... chemically pure phospholipids.
@ast
Chromatographic retention of d ...... chemically pure phospholipids.
@en
P2093
P1476
Chromatographic retention of d ...... chemically pure phospholipids.
@en
P2093
Osterberg T
Svensson M
P304
P356
10.1016/S0928-0987(00)00183-4
P407
P577
2001-02-01T00:00:00Z